Scolaris Content Display Scolaris Content Display

Vedolizumab for induction and maintenance of remission in Crohn’s disease

This protocol has been withdrawn

Reason for withdrawal from publication

This protocol is being withdrawn because the composition of the author team does not adhere to Cochrane COI policy.